Submit manuscript...
Journal of
eISSN: 2376-0060

Lung, Pulmonary & Respiratory Research

Editorial Volume 9 Issue 2

Devastating effect of COVID-19 on tuberculosis management and care

Attapon Cheepsattayakorn,1,2 Ruangrong Cheepsattayakorn,3 Porntep Siriwanarangsun1

1Faculty of Medicine, Western University, Thailand
210th Zonal Tuberculosis and Chest Disease Center, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand

Correspondence: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Changklan Muang Chiang Mai 50100 Thailand

Received: April 25, 2022 | Published: April 28, 2022

Citation: Cheepsattayakorn A, Cheepsattayakorn R, Siriwanarangsun P. Devastating effect of COVID-19 on tuberculosis management and care. J Lung Pulm Respir Res. 2022;9(2):36. DOI: 10.15406/jlprr.2022.09.00275

Download PDF


The World Health Organization (WHO) Global Tuberculosis Report 2021 revealed worsening case notification and increased tuberculosis mortality due to pandemic-associated-service disruptions. As of December 31, 2021, about 8% and 76% of the people in low-income and high-income countries received at least one dose of COVID-19 vaccine, respectively. Approximately, 18% decrease of the estimated tuberculosis cases from 2019, particularly China, India, Indonesia, and the Philippines with healthcare service disruptions and major COVID-19 outbreak was demonstrated. Negative COVID-19-pandemic-associated effects included 15% decrease in number of drug-resistant-tuberculosis cases, 21% reduction in number of tuberculosis-preventive-treatment cases, and around 1.5 million tuberculosis death worldwide in 2020, contributing to off-tracking of the United Nations (UN) high-level meeting on 2022-tuberculosis-target establishment. By driving and ongoing COVID-19 surges in low- and middle-income countries, decrease in tuberculosis incidence dramatically have slowed.1 By failure in targeting the Sustainable Development Goals (SDG)’s tuberculosis mortality in 2030 would lead to vast economic and health losses.2

In conclusion, tuberculosis-field-working people should support the WHO plans and the Group of 20 Rome leaders’ declaration of both COVID-19 (70% of the world populations vaccinated by mid-2022) and tuberculosis. Tuberculosis programs should learn the real-time COVID-19 dashboards that are widely available.



Conflicts of interest



Creative Commons Attribution License

©2022 Cheepsattayakorn, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.